MedPath

Change in diuretic dose after administration of Tolvaptan in liver cirrhosis patients with ascites

Not Applicable
Recruiting
Conditions
liver cirrhosis
Registration Number
JPRN-UMIN000038304
Lead Sponsor
Kitasato University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1)The anuric patients 2)Patients with urinary retention 3)Serum Na >=147mEq/

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath